Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014)
Bio-Techne's quarterly Amortization - Intangibles came in at $5.7 million in Q3 2014, up 161.79% year-on-year from $2.2 million in Q3 2013, and up 161.79% quarter-over-quarter from $2.2 million in Q3 2013.
Bio-Techne has reported Amortization - Intangibles for 5 years, with the latest figure at $5.7 million in Q3 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 5.73 Mn |
| Sep 30, 2013 | 2.19 Mn |
| Mar 31, 2011 | 170,000.00 |
| Dec 31, 2010 | 171,000.00 |
| Sep 30, 2010 | 170,000.00 |
| Mar 31, 2010 | 240,000.00 |
| Dec 31, 2009 | 240,000.00 |
| Sep 30, 2009 | 240,000.00 |